Market Currents
AstraZeneca (AZN -0.1%) will appoint a new CEO over the next six months and the person should be...
-
Thursday, May 31, 2012, 2:30 PM ETAstraZeneca (AZN -0.1%) will appoint a new CEO over the next six months and the person should be aggressive on acquisitions, according to Leerink Swann. Leerink views Forest Labs (FRX +3.5%), a stock it upgraded this morning to Outperform, as the most logical takeover target for AZN, but also feels the company has several other options, including Amylin (AMLN -2.7%) and Salix (SLXP -0.1%).
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
